Annandale Capital’s Elevation Oncology ELEV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-50,000
| Closed | -$27K | – | 135 |
|
|
2023
Q4 | $27K | Hold |
50,000
| – | – | 0.01% | 129 |
|
|
2023
Q3 | $33K | Hold |
50,000
| – | – | 0.01% | 126 |
|
|
2023
Q2 | $76K | Hold |
50,000
| – | – | 0.02% | 128 |
|
|
2023
Q1 | $95K | Hold |
50,000
| – | – | 0.03% | 124 |
|
|
2022
Q4 | $48K | Buy |
50,000
+20,000
| +67% | +$19.2K | 0.02% | 128 |
|
|
2022
Q3 | $34K | Buy |
+30,000
| New | +$34K | 0.01% | 132 |
|